Login / Signup

Post-transplant diabetes mellitus and renal cell cancer after renal transplantation.

Esteban PorriniNuria Montero PérezJuan Manuel DíazRicardo LauzurricaJuana Oramas RodríguezIrene Silva TorresFrancesc MoresoJosep M Cruzado GarritRocío Benítez RuizMeritxel Ibernon VilaróMaria Xixiang Molina LimaSimran Khemlani RamchandJuan Carlos RuizFrancisco Gainza de Los RiosCarla Rodríguez AlvarezMaría Del Carmen de Gracia GuindoManuel MacíasDavid Bonet VelaAntonio OsunaBeatriz Bayés-GenísCristina Aleman SanchezMaría Del Carmen RuizAna Elena Rodríguez RodríguezRosa Domínguez RollánFederico González RinneAlejandro Jiménez SosaPatricia Delgado MallénAna González RinneDomingo Marrero MirandaArmando Torres
Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
Patients with PTDM must be considered a population at risk for RCC and accordingly, susceptible of active surveillance.
Keyphrases
  • papillary thyroid
  • single cell
  • cell therapy
  • squamous cell
  • renal cell carcinoma
  • lymph node metastasis
  • glycemic control
  • mesenchymal stem cells